Among genetic aberrations potentially related to the development of AML or prognosis assessment among patients, changes in genes coding for the so-called transcription factors (including RUNX1, RUNX3, CEBPA, ASXL1) regulating transcription processes as well as controlling the cell differentiation and formation seem significant [4, 6]. Here, RUNX1 is linked to acute myeloid leukemia.